Clinical Trial Update: Add On Treatment for Cognitive Deficits in Schizophrenia [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an add-on treatment for cognitive deficits in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: University of Pennsylvania | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED